Pakistan Performs First-Ever Specialized Cell-Based Cancer Treatment

Pakistan has achieved a major breakthrough in advanced cancer care after the Armed Forces Bone Marrow Transplant Center (AFBMTC) in Rawalpindi successfully carried out the country’s first CAR T-cell therapy.

The treatment was given to a 21-year-old patient suffering from relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL), a serious form of blood cancer that had returned twice despite earlier treatment.

According to details shared by the center, the patient received indigenously prepared anti-CD19 CAR T-cell therapy on June 18, 2026 and achieved measurable residual disease (MRD)-negative complete remission by Day 14. He was later discharged on July 3, 2026.

A Historic Milestone for Pakistan’s Medical Frontier

Armed Forces Bone Marrow Transplant Centre (AFBMTC), Rawalpindi, is proud to announce *the successful completion of the first CAR T-cell therapy in Pakistan. Alhamdulilah* The recipient,a 21-year-old patient with… pic.twitter.com/PCbYYV2CgQ

— War Analyst (@War_Analysts) July 4, 2026

The development marks a major milestone for Pakistan’s medical sector, as CAR T-cell therapy is considered one of the most advanced forms of cancer treatment and has remained limited even in many parts of the world.

The therapy offers a potential treatment option for patients who have exhausted conventional lines of care, particularly in aggressive blood cancers.

AFBMTC said the achievement was the result of years of preparation by its physicians, apheresis and cell-processing scientists, laboratory experts, and nursing staff working under the Army Medical Corps.

The center also acknowledged the courage and trust shown by the patient and his family in undergoing the pioneering treatment.

The successful procedure opens the door for wider use of cellular and immune-effector therapies in Pakistan and could pave the way for more patients to access highly specialized cancer treatment within the country.